PHAXIAM Therapeutics S.A. Sponsored ADR Debt to Equity Ratio 2017-2023 | PHXM

Current and historical debt to equity ratio values for PHAXIAM Therapeutics S.A. Sponsored ADR (PHXM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. PHAXIAM Therapeutics S.A. Sponsored ADR debt/equity for the three months ending June 30, 2023 was .
Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-06-30 $0.03B $0.04B 0.79
2019-09-30 $0.04B $0.12B 0.31
2019-06-30 $0.03B $0.13B 0.24
2018-12-31 $0.03B $0.17B 0.15
2017-12-31 $0.02B $0.21B 0.08
2017-06-30 $0.01B $0.10B 0.13
2016-12-31 $0.01B $0.04B 0.26